SQM up +4.37% percent Today $SQM High is at 26.79 and the

New Post Public Reply Private Reply Replies (0) Message Board

Nov 19, 2014 at 11:20 AM

SQM up +4.37% percent Today $SQM High is at 26.79 and the Low 25.60 with current volume of 159,403.

Recent News posted below.

Sociedad Quimica Y Minera S.A. SQM other info.
http://investorshangout.com/Sociedad-Quimica-...SQM-52700/

SQM Sociedad Quimica Y Minera S.A. Recent Headline News

Sociedad Quimica y Minera de Chile misses by $0.04, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Nov 19, 2:04AM CST

SQM: 26.20 (+1.05)

SQM Reports Earnings For The Third Quarter 2014
PR Newswire - Tue Nov 18, 5:29PM CST
Sociedad Quimica y Minera de Chile S.A. (SQM) (NYSE: SQM; Santiago Stock Exchange: SQM-B, SQM-A) reported today earnings for the nine months ended September 30, 2014 of US$218.4 million (US$0.83 per ADR), a decrease from US$398.1 million (US$1.51 per ADR) for the nine months ended September 30, 2013. Gross margin reached US$442.6 million (29.1% of revenues) for the nine months ended September 30, 2014, lower than US$575.2 million (33.6% of revenues) recorded for the nine months ended September 30, 2013. Revenues totaled US$1,522.8 million for the nine months ended September 30, 2014, representing a decrease of 11.0% compared to US$1,710.9 million reported for the nine months ended September 30, 2013.
SQM: 26.20 (+1.05)

Sociedad Quimica y Minera de Chile Shares Down 10.4% Since SmarTrend's Sell Call (SQM)
Comtex SmarTrend(R) - Tue Nov 18, 5:02PM CST
SmarTrend identified a Downtrend for Sociedad Quimica y Minera de Chile (NYSE:SQM) on May 15th, 2014 at $28.08. In approximately 6 months, Sociedad Quimica y Minera de Chile has returned 10.43% as of today's recent price of $25.15.
SQM: 26.20 (+1.05)

16.5% Return Seen to Date on SmarTrend Sociedad Quimica y Minera de Chile Call (SQM)
Comtex SmarTrend(R) - Tue Nov 11, 11:06AM CST
SmarTrend identified a Downtrend for Sociedad Quimica y Minera de Chile (NYSE:SQM) on May 15th, 2014 at $28.08. In approximately 6 months, Sociedad Quimica y Minera de Chile has returned 16.52% as of today's recent price of $23.44.
SQM: 26.20 (+1.05)

SQM Filed Its Annual Report On Form 20-F For The Year 2013 On April 29, 2014
PR Newswire - Thu Oct 30, 4:34PM CDT
Sociedad Quimica y Minera de Chile S.A. (SQM) (NYSE: SQM; Santiago Stock Exchange: SQM-A, SQM- announced today that it filed its Annual Report on Form 20-F for the year 2013 with the U.S. Securities and Exchange Commission on April 29, 2014. The Form 20-F is available on the Company's website (www.sqm.com).
SQM: 26.20 (+1.05)

Shares of SQM Down 18.3% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Tue Oct 28, 9:17AM CDT
SmarTrend identified a Downtrend for Sociedad Quimica y Minera de Chile (NYSE:SQM) on May 15th, 2014 at $28.08. In approximately 6 months, Sociedad Quimica y Minera de Chile has returned 18.34% as of today's recent price of $22.93.
SQM: 26.20 (+1.05)

SQM announces pricing of Notes due 2025
PR Newswire - Thu Oct 23, 5:41PM CDT
Sociedad Quimica y Minera de Chile S.A. (SQM) (NYSE: SQM; Santiago Stock Exchange: SQM-A, SQM- reported that it has priced today a US$250 million aggregate principal amount of 4.375% Notes due 2025 (equivalent to a spread of 215 basis points over the US treasury). The notes were offered to investors at a price of 99.410% of principal amount.
SQM: 26.20 (+1.05)

Orocobre Provides Exposure To Lithium M&A Activity
Livio Filice - at Seeking Alpha - Wed Oct 22, 4:58PM CDT

SQM: 26.20 (+1.05), ROC: 78.77 (-0.21), ALB: 61.25 (-0.44), FMC: 56.29 (-0.50), TM: 119.56 (-0.51)

Sociedad Quimica y Minera de Chile Has Returned 17.9% Since SmarTrend Recommendation (SQM)
Comtex SmarTrend(R) - Mon Oct 20, 5:05PM CDT
SmarTrend identified a Downtrend for Sociedad Quimica y Minera de Chile (NYSE:SQM) on May 15th, 2014 at $28.08. In approximately 5 months, Sociedad Quimica y Minera de Chile has returned 17.91% as of today's recent price of $23.05.
SQM: 26.20 (+1.05)

Sociedad Quimica y Minera de Chile (SQM): Moving Average Crossover Alert - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 03, 8:37AM CDT
Sociedad Quimica y Minera de Chile (SQM): Moving Average Crossover Alert
SQM: 26.20 (+1.05)

Sociedad Quimica y Minera de Chile Earnings In Retrospect: Down 2.9% in the Last 20 Days (SQM)
Comtex SmarTrend(R) - Mon Sep 15, 6:56AM CDT
Two weeks ago on August 26th, 2014 Sociedad Quimica y Minera de Chile (NYSE:SQM) reported earnings and analysts, on average, expected earnings of $0.31 on sales of $520.6 million. The company actually reported a break-even quarter on sales of $522.3 million, missing EPS estimates by $0.31 and beating revenue estimates by $1.7 million. Shares of Sociedad Quimica y Minera de Chile have slipped from $28.14 to $27.33, representing a loss of 2.9%, since the company reported earnings 20 days ago.
SQM: 26.20 (+1.05)

Post Earnings Update: Sociedad Quimica y Minera de Chile Has Sunk 0.8% Lower in Past Week (SQM)
Comtex SmarTrend(R) - Mon Sep 08, 7:03AM CDT
13 days ago, on August 26th, 2014, Sociedad Quimica y Minera de Chile (NYSE:SQM) reported its earnings. Analysts, on average, expected earnings of $0.31 per share on sales of $520.6 million. The company actually reported a break-even quarter on sales of $522.3 million, missing EPS estimates by $0.31 and beating revenue estimates by $1.7 million. Since the company's report, shares of Sociedad Quimica y Minera de Chile have fallen from $28.14 to $27.91, representing a loss of 0.8% in the past 13 days.
SQM: 26.20 (+1.05)

What To Hold: 3 Hold-Rated Dividend Stocks LINE, LPT, SQM
at The Street - Tue Sep 02, 10:30AM CDT
These 3 dividend stocks are rated a Hold by TheStreet
SQM: 26.20 (+1.05), LPT: 35.18 (-0.18), LINE: 22.76 (-0.19)

SQM posts lower net income of USD71.1m for Q2 2014
M2 - Wed Aug 27, 3:05AM CDT
Plant nutrients company Sociedad Quimica y Minera de Chile S.A. (NYSE:SQM)(Santiago Stock Exchange:SQM- (Santiago Stock Exchange:SQM-A) Tuesday announced its net income of USD71.1m (USD0.27 per ADR) for the Q2 2014.
SQM: 26.20 (+1.05)

SQM Reports Earnings For The Second Quarter 2014
PR Newswire Europe - Tue Aug 26, 7:37PM CDT
Sociedad Quimica y Minera de Chile S.A. (SQM) reported today earnings for the six months ended June 30, 2014 of US$152.1 million (US$0.58 per ADR), a decrease from US$259.2 million (US$0.98 per ADR) for the six months ended June 30, 2013. Gross Margin(2 )reached US$300.2 million (28.4% of revenues) for the six months ended June 30, 2014, lower than US$426.7 million (35.9% of revenues) recorded for the six months ended June 30, 2013. Revenues totaled US$1,056.4 million for the six months ended June 30, 2014, representing a decrease of 11.2% compared to US$1,189.9 million reported for the six months ended June 30, 2013.
SQM: 26.20 (+1.05)

CF Industries (CF) Remains on Track with Expansion Projects - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 18, 12:20PM CDT
We have issued an updated research report on fertilizer maker CF Industries (CF).
SQM: 26.20 (+1.05), CE: 60.48 (-0.40), CF: 272.56 (+2.87)

Sociedad Quimica Y Minera S.A. (SQM) Stock Research Links

SQM Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Master Sommeliers and Italian Producers Clash on Wine Lists

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Apalutamide Boosts Outlook for Prostate Cancer Treatment

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Swanson Nexus Pro Launch: Boost for Dietitians

By Lucas Young Updated Oct 24, 2026 Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Aluminum Design Fumble: Geometry Over Wall Thickness

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Bio-Thera's New Data: A Game Changer for NSCLC?

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...